NCT03645135 is a NA clinical trial of Goal elicitation in Orthopedic Disorder, sponsored by Stanford University.

Who is sponsoring NCT03645135?

NCT03645135 is sponsored by Stanford University.

What drugs are being tested in NCT03645135?

Interventions in NCT03645135: Goal elicitation.

What condition does NCT03645135 study?

NCT03645135 studies Orthopedic Disorder.

Is NCT03645135 still recruiting?

NCT03645135 is currently completed. Last updated 10 April 2019.

Last reviewed 2019-04-10 · How we verify

NCT03645135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Does Goal Elicitation Improve Patient Perceived Involvement

Completed NA Last updated 10 April 2019

What this trial tests

NA trial testing Goal elicitation in Orthopedic Disorder in 90 participants. Completed in 19 November 2018.

Timeline

1 July 2018

Primary endpoint
19 November 2018

19 November 2018

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	90
Start date	1 July 2018
Primary completion	19 November 2018
Estimated completion	19 November 2018
Sites	1 location across United States

Drugs / interventions tested

Goal elicitation

Conditions studied

Orthopedic Disorder — all drugs for Orthopedic Disorder →

Sponsor

Stanford University

Who can join

18 and older, any sex, with Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if goal elicitation among orthopaedic patients improves their perceived involvement in care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Orthopedic Disorder

Currently open trials in the same condition.

NCT06991205 — Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain · NA · recruiting
NCT06002009 — SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function · recruiting
NCT06869343 — Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture · NA · recruiting
NCT06877078 — Effect of Pre-Surgery Constipation Podcast: A RCT · NA · recruiting
NCT06579599 — Study on the Preventive Effect of Establishing an Integrated Working Group of Doctors and Nurses in Operating Room · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03645135 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 10 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03645135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing